Drugs / Tumor Infiltrating Lymphocyte Therapy
Tumor Infiltrating Lymphocyte Therapy
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07647068 | Aug 2026 → Dec 2027 expected | gastrointestinal stromal tumor | Joal Beane | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tumor Infiltrating Lymphocyte Therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07647068 ↗ |
| Modality | Cell therapy | “Autologous TILs are made using the patient's own tumor cells collected from a previous surgery.” NCT07647068 ↗ |
| Route | Intravenous | “Given IV” NCT07647068 ↗ |